| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.043 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |